spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Poniard Pharmaceuticals 

 HSMN NewsFeed - 15 Dec 2016
Celldex Therapeutics Announces Appointment to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Oct 2013
Gregory L. Weaver Joins Atossa Genetics' Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 23 Apr 2012
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2012
NeurogesX Appoints Ronald Martell President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2011
Poniard Pharmaceuticals and Allozyne Terminate Planned Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2010
Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2009
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2009
Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Caroline Loewy Joins Corcept as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Nov 2008
Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2008
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2007
Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Sep 2007
Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2007
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Poniard Pharmaceuticals Announces Results of Picoplatin Phase 2 Trial That Confirm and Extend Survival Benefit in Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2007
Molecular Insight Pharmaceuticals, Inc. Enters into Agreement to Purchase Radiopharmaceutical Manufacturing Facility
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2007
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2007
Poniard Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase 3 Trial of Picoplatin for Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Nov 2006
Poniard Announces Positive Interim Survival Results from Ongoing Phase 2 Trial of Picoplatin for Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2006
AnorMED amends license agreement for cancer drug
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Sep 2006
Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Conditions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jul 2006
Poniard Pharmaceuticals Appoints Alan B. Glassberg, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2006
Poniard Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2006
NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line Prostate Cancer Trial
Biopharmaceuticals Oncology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.